Original Research
Published on 13 Sep 2024
Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis
in Pharmacology of Infectious Diseases
- 2,031 views